The early results of the French national transcatheter aortic valve implantation registry, FRANCE 2 (FRench Aortic National CoreValve and Edwards registry), were reported previously (1). The initial report of FRANCE 2 identified the need for safer and more effective technology to reduce the need for alternative access and the high rates of paravalvular leakage. The current publication in this issue of the Journal includes longer-term outcomes of 4,201 patients treated at all sites in France from January 2010 to January 2012 (2). The registry has multiple positive attributes including use of a clinical events committee to adjudicate the cause of mortality.
http://ift.tt/2dCZ9R2
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Ετικέτες
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: September 2017 Source: European Journal of Surgical Oncology (EJSO), Volume 43, Issue 9 http://ift.tt/2gezJ2D
-
Publication date: January–February 2018 Source: Materials Today, Volume 21, Issue 1 Author(s): David Bradley http://ift.tt/2BP...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου